The estimated Net Worth of David L. Ralph is at least 1.62 百万$ dollars as of 11 February 2021. Mr. Ralph owns over 5,000 units of Simulations Plus stock worth over 387,224$ and over the last 12 years he sold SLP stock worth over 1,041,883$. In addition, he makes 193,867$ as Independent Director at Simulations Plus.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Ralph SLP stock SEC Form 4 insiders trading
David has made over 4 trades of the Simulations Plus stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of SLP stock worth 421,700$ on 11 February 2021.
The largest trade he's ever made was selling 5,000 units of Simulations Plus stock on 11 February 2021 worth over 421,700$. On average, David trades about 493 units every 20 days since 2012. As of 11 February 2021 he still owns at least 11,802 units of Simulations Plus stock.
You can see the complete history of Mr. Ralph stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Ralph biography
Dr. David L. Ralph Ph.D. serves as Independent Director of the Company.D serves as Independent Director of the Company. serves as Independent Director of the Company. Mr. Ralph has served as a Director of the Company since March 2012. He is currently a Professor of Marketing at Pepperdine University, and has been on the faculty since 1968. He is a member of the Pepperdine 2020 Strategic Planning Committee and the Marketing Task Force. Dr. Ralph also serves as the Chair of the Fully Employed MBA Program Administrative Committee and is a member of the University Faculty Council at Pepperdine. He has consulted with key executives in a wide range of industries on marketing. He also acted as President and Chief Executive Officer of Antelope Valley Christian School from 1986 to 2005. He has served as the Associate Dean of The Graziadio School of Business and Management at Pepperdine University and currently serves as the Chair of the Department of Economics, Law, and Marketing. His business experience, knowledge of business operations, and marketing skills qualify him as a candidate for the Board.
What is the salary of David Ralph?
As the Independent Director of Simulations Plus, the total compensation of David Ralph at Simulations Plus is 193,867$. There are 11 executives at Simulations Plus getting paid more, with Shawn M. O'Connor having the highest compensation of 544,231$.
How old is David Ralph?
David Ralph is 72, he's been the Independent Director of Simulations Plus since 2012. There are 2 older and 12 younger executives at Simulations Plus. The oldest executive at Simulations Plus Inc. is Walter S. Woltosz M.A.S., M.S., 76, who is the Co-Founder & Chairman.
What's David Ralph's mailing address?
David's mailing address filed with the SEC is 42505, 10th Street West, Lancaster, California, 93534, United States.
Insiders trading at Simulations Plus
Over the last 21 years, insiders at Simulations Plus have traded over 70,055,940$ worth of Simulations Plus stock and bought 24,000 units worth 1,395,840$ . The most active insiders traders include Walter Swoltosz Virginia E ...、Walter S Woltosz、Momoko A Beran. On average, Simulations Plus executives and independent directors trade stock every 37 days with the average trade being worth of 571,025$. The most recent stock trade was executed by Jill Fiedler Kelly on 9 September 2024, trading 2,250 units of SLP stock currently worth 21,848$.
What does Simulations Plus do?
simulations plus, inc. (nasdaq: slp) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. we partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical trials/post approval. with our subsidiaries, cognigen corporation and dilisym services, we offer #1-ranked, easy-to-use software (gastroplus™, admet predictor™, kiwi™, dilisym®, nafldsym®, pkplus™, and more) to bridge data mining, compound library screening with qsar models, pbpk/tk modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. simulations plus technology is licensed to and used by regulatory agencies worldwide. for over 20 years, simulations plus has partnered with our clients to reduce costs and accelerate res
What does Simulations Plus's logo look like?
Complete history of Mr. Ralph stock trades at Simulations Plus
Simulations Plus executives and stock owners
Simulations Plus executives and other stock owners filed with the SEC include:
-
Shawn M. O'Connor,
Chief Exec. Officer -
Shawn O'Connor,
Chief Executive Officer -
William Frederick,
CFO & Sec. -
John DiBella,
President, Lancaster Division -
John Anthony DiBella M.S.,
Pres of Lancaster Division -
Thaddeus Grasela,
Senior Advisory Capacity -
John Kneisel,
Chief Financial Officer -
Jill Fiedler-Kelly M.S., MS,
Pres of Cognigen Division -
Dr. Brett A. Howell Ph.D.,
Pres of DILIsym Services, Inc -
Dr. Brett A. Howell,
Pres of DILIsym Services, Inc -
John Paglia,
Independent Director -
Daniel Weiner,
Independent Director -
David Ralph,
Independent Director -
Walter Woltosz,
Chairman of the Board -
Walter S. Woltosz M.A.S., M.S.,
Co-Founder & Chairman -
Lisa LaVange,
Independent Director -
Renee Bouche,
IR Contact Officer -
Jill Fiedler-Kelly,
President - Cognigen division -
Dr. Scott Q. Siler,
Chief Scientific Officer of DILIsym Services, Inc -
Lindsay Luke,
Exec. Director of HR -
Arlene Padron,
Corp. Director of Marketing -
Viera Lukacova Ph.D.,
Chief Scientific Officer -
Argenio David Z D,
Director -
Brett Howell,
Business Unit President -
Steven Chang,
President, Immunetrics -
William W Frederick,
CFO -
Walter Swoltosz Virginia E ...,
-
Walter S Woltosz,
Director -
Richard R Weiss,
Director -
Momoko A Beran,
Chief Financial Officer -
Harold Wayne Rosenberger,
Director -
Jeffrey A Dahlen,
VP, Research & Development -
Virginia E Woltosz,
Secretary/Treasurer -
Ronald F Creeley,
VP Marketing & Sales -
Daniel Szot,
Chief Revenue Officer -
Sharlene Evans,
Director